StockWatch
·
Medical Specialities
MergerAug 4, 2026, 04:24 PM

Personalis to Merge with Tempus AI; Q2 Net Loss $(31.68)M, Revenue $22.36M

AI Summary

Personalis, Inc. announced it entered into a Merger Agreement with Tempus AI, Inc. on July 20, 2026, with the completion subject to various conditions. Concurrently, the company reported its Q2 2026 financial results, with revenue increasing to $22.36 million from $17.20 million year-over-year. However, the net loss widened significantly to $(31.68) million compared to $(20.06) million in the prior year quarter. The company also noted a decrease in cash and cash equivalents and an increase in its accumulated deficit.

Key Highlights

  • Personalis entered a Merger Agreement with Tempus AI, Inc. on July 20, 2026.
  • Q2 2026 revenue increased to $22.36M from $17.20M year-over-year.
  • Q2 2026 net loss widened to $(31.68)M from $(20.06)M year-over-year.
  • YTD June 30, 2026 net loss widened to $(61.72)M from $(35.81)M year-over-year.
  • Cash and cash equivalents decreased to $93.97M from $124.25M since Dec 31, 2025.
  • Merck & Co., Inc. accounted for 37% of Q2 2026 revenue.
  • Total assets decreased to $312.14M from $334.16M since Dec 31, 2025.
  • Accumulated deficit increased to $(692.98)M from $(631.26)M since Dec 31, 2025.